Amyotrophic Lateral Sclerosis (ALS)

This fatal neurodegenerative disorder is characterized by the selective loss of motor neurons in the spinal cord, brain stem and motor cortex. An estimated 30,000 Americans are living with ALS, and more than half of patients die within 2.5 years following the onset of symptoms. Preclinical findings have supported anecdotal reports by patients that medical cannabis may help in moderating the disease’s development and in alleviating pain, appetite loss and depression.  Recent preclinical findings indicate that medical cannabis use might delay ALS progression and reduce symptom severity.